ALLStrong Buy
Allstate
Price (1y)
Fair price check
4 different valuation methods each estimate what ALL should be worth, then we compare to today's price.
- P/E multiplesUndervaluedthinks it's a bargain — estimates $651.13, about 200% above today
- P/B multiplesFairthinks it's fairly priced — estimates $246.85, about 14% above today
- Graham (defensive)Fairthinks it's fairly priced — estimates $209.34, about 4% below today
- Residual IncomeOvervaluedthinks it's expensive — estimates $154.78, about 29% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
| Method | Value |
|---|---|
| Graham (defensive) | $209.34 |
| P/E multiples(vs sector peers) | $651.13 |
| P/B multiples(vs sector peers) | $246.85 |
| EV/EBITDA | skipped |
| Residual Income | $154.78 |
| DCF (2-stage) | skipped |
Median of all applicable methods (current price $217.37). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Pillar breakdown
8 dimensions, each scored 0–100 against the universe
- QualityProfit margins & asset efficiency70Strong
- ValuePrice vs fundamentals74Strong
- GrowthRevenue & earnings trajectory73Strong
- MomentumRecent price strength66Decent
- HealthBalance sheet & solvency56Decent
- ProfitabilityROE, ROA, ROIC55Decent
- TechnicalTrend & volatility signals61Decent
- RiskVolatility & drawdown profile74Strong
Pillars not shown: Sentiment, ML (Phase 5+).
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $55.96B |
| Revenue (TTM) | $68.17B |
| Net income (TTM) | $12.14B |
| Operating cash flow (TTM) | $11.71B |
| CapEx (TTM) | $269.00M |
| Free cash flow (TTM)CFO − CapEx | $11.44B |
| Total assets | $123.97B |
| Total liabilities | $92.39B |
| Stockholders' equity | $31.61B |
| Cash & equivalents | $697.00M |
| Shares outstanding | 257.42M |
| EPS (basic) | $9.36 |
| EPS (diluted) | $9.25 |
| P/E ratio (TTM) | 4.61 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-04-29
- Latest period end
- 2026-04-13
- Filing lag
- 17 days
- Missing metrics
- 13(gross_profit, operating_income, cost_of_revenue, research_and_development, sga_expense, depreciation_and_amortization, income_before_tax, current_assets, current_liabilities, inventory, accounts_receivable, accounts_payable, ebitda)
Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.